These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation. Sackett SD; Brown ME; Tremmel DM; Ellis T; Burlingham WJ; Odorico JS Transplant Rev (Orlando); 2016 Apr; 30(2):61-70. PubMed ID: 26970668 [TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cell-derived gamete-associated proteins incite rejection of induced pluripotent stem cells in syngeneic mice. Kim EM; Manzar G; Zavazava N Immunology; 2017 Jun; 151(2):191-197. PubMed ID: 28185259 [TBL] [Abstract][Full Text] [Related]
4. Enhanced wound healing promotion by immune response-free monkey autologous iPSCs and exosomes vs. their allogeneic counterparts. Lu M; Peng L; Ming X; Wang X; Cui A; Li Y; Wang X; Meng D; Sun N; Xiang M; Chen S EBioMedicine; 2019 Apr; 42():443-457. PubMed ID: 30926422 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of induced pluripotent stem cells. Zhao T; Zhang ZN; Rong Z; Xu Y Nature; 2011 May; 474(7350):212-5. PubMed ID: 21572395 [TBL] [Abstract][Full Text] [Related]
6. Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation. Giallongo S; Rehakova D; Raffaele M; Lo Re O; Koutna I; Vinciguerra M Antioxid Redox Signal; 2021 Feb; 34(4):335-349. PubMed ID: 32567336 [No Abstract] [Full Text] [Related]
7. The genomic stability of induced pluripotent stem cells. Chen Z; Zhao T; Xu Y Protein Cell; 2012 Apr; 3(4):271-7. PubMed ID: 22528751 [TBL] [Abstract][Full Text] [Related]
13. Clinical therapy using iPSCs: hopes and challenges. Lu X; Zhao T Genomics Proteomics Bioinformatics; 2013 Oct; 11(5):294-8. PubMed ID: 24060840 [TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cell consensus genes: implication for the risk of tumorigenesis and cancers in induced pluripotent stem cell therapy. Zhang G; Shang B; Yang P; Cao Z; Pan Y; Zhou Q Stem Cells Dev; 2012 Apr; 21(6):955-64. PubMed ID: 22185567 [TBL] [Abstract][Full Text] [Related]
15. Cells derived from iPSC can be immunogenic - yes or no? Cao J; Li X; Lu X; Zhang C; Yu H; Zhao T Protein Cell; 2014 Jan; 5(1):1-3. PubMed ID: 24474200 [TBL] [Abstract][Full Text] [Related]
16. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Guha P; Morgan JW; Mostoslavsky G; Rodrigues NP; Boyd AS Cell Stem Cell; 2013 Apr; 12(4):407-12. PubMed ID: 23352605 [TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Liang G; Zhang Y Cell Stem Cell; 2013 Aug; 13(2):149-59. PubMed ID: 23910082 [TBL] [Abstract][Full Text] [Related]
18. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs. Menon S; Shailendra S; Renda A; Longaker M; Quarto N Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822 [TBL] [Abstract][Full Text] [Related]